Noteworthily, ITPR3 was significantly upregulated in pancreatic cancer patients in six datasets with low p-value much lower than 0.05, such as 1.83e-7, 6.03e-8 [24–29]. This evidence concerns the gene ITPR3 and pancreatic neoplasm.